Published in Virology on January 01, 1994
Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly. Proc Natl Acad Sci U S A (1996) 4.83
Structural organization of authentic, mature HIV-1 virions and cores. EMBO J (2003) 4.32
Virus maturation by budding. Microbiol Mol Biol Rev (1998) 3.78
In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain. J Virol (1999) 3.34
Supramolecular organization of immature and mature murine leukemia virus revealed by electron cryo-microscopy: implications for retroviral assembly mechanisms. Proc Natl Acad Sci U S A (1998) 3.24
Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism. J Virol (1997) 3.07
Organization of immature human immunodeficiency virus type 1. J Virol (2001) 2.34
Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins. J Virol (2001) 2.04
Genetic determinants of Rous sarcoma virus particle size. J Virol (1998) 1.67
Detection of a trimeric human immunodeficiency virus type 1 Gag intermediate is dependent on sequences in the matrix protein, p17. J Virol (1998) 1.66
A synergistic approach to protein crystallization: combination of a fixed-arm carrier with surface entropy reduction. Protein Sci (2010) 1.66
Roles of matrix, p2, and N-terminal myristoylation in human immunodeficiency virus type 1 Gag assembly. J Virol (2000) 1.55
In vitro selection of RNAs that bind to the human immunodeficiency virus type-1 gag polyprotein. Nucleic Acids Res (1997) 1.53
Structure-function studies of the human immunodeficiency virus type 1 matrix protein, p17. J Virol (1997) 1.48
Virus particle core defects caused by mutations in the human immunodeficiency virus capsid N-terminal domain. J Virol (2005) 1.24
Human immunodeficiency virus type 1 MA deletion mutants expressed in baculovirus-infected cells: cis and trans effects on the Gag precursor assembly pathway. J Virol (1995) 1.24
Human immunodeficiency virus type 1 matrix protein assembles on membranes as a hexamer. J Virol (2006) 1.17
HIV-1 matrix organizes as a hexamer of trimers on membranes containing phosphatidylinositol-(4,5)-bisphosphate. Virology (2009) 1.16
A molecular determinant of human immunodeficiency virus particle assembly located in matrix antigen p17. J Virol (1995) 1.13
Assembly of retrovirus capsid-nucleocapsid proteins in the presence of membranes or RNA. J Virol (2000) 1.08
Analysis of Mason-Pfizer monkey virus Gag particles by scanning transmission electron microscopy. J Virol (2001) 1.07
Murine leukemia virus particle assembly quantitated by fluorescence microscopy: role of Gag-Gag interactions and membrane association. J Virol (2003) 1.05
Molecular organization of Mason-Pfizer monkey virus capsids assembled from Gag polyprotein in Escherichia coli. J Virol (2002) 1.02
Structure of equine infectious anemia virus matrix protein. J Virol (2002) 1.01
The solution structure of the bovine leukaemia virus matrix protein and similarity with lentiviral matrix proteins. EMBO J (1996) 1.01
Total chemical synthesis of N-myristoylated HIV-1 matrix protein p17: structural and mechanistic implications of p17 myristoylation. Proc Natl Acad Sci U S A (2004) 1.01
Structural flexibility and functional valence of CD4-IgG2 (PRO 542): potential for cross-linking human immunodeficiency virus type 1 envelope spikes. J Virol (2001) 0.91
Cryoelectron microscopic examination of human immunodeficiency virus type 1 virions with mutations in the cyclophilin A binding loop. J Virol (1998) 0.90
Structural consequences of cyclophilin A binding on maturational refolding in human immunodeficiency virus type 1 capsid protein. J Virol (2001) 0.89
Cryo-electron microscopy structure of yeast Ty retrotransposon virus-like particles. J Virol (1997) 0.89
A highly conserved residue in the C-terminal helix of HIV-1 matrix is required for envelope incorporation into virus particles. J Virol (2011) 0.89
Discovery of a small-molecule antiviral targeting the HIV-1 matrix protein. Bioorg Med Chem Lett (2012) 0.85
Atomic force microscopy and electron microscopy analysis of retrovirus Gag proteins assembled in vitro on lipid bilayers. Biophys J (2000) 0.84
Effect of extension of the cytoplasmic domain of human immunodeficiency type 1 virus transmembrane protein gp41 on virus replication. J Virol (2004) 0.81
Biophysical characterization and crystal structure of the Feline Immunodeficiency Virus p15 matrix protein. Retrovirology (2013) 0.81
Biophysical characterization of the feline immunodeficiency virus p24 capsid protein conformation and in vitro capsid assembly. PLoS One (2013) 0.79
Prevention of disabling and fatal strokes by successful carotid endarterectomy in patients without recent neurological symptoms: randomised controlled trial. Lancet (2004) 12.59
Exposure measurement error in time-series studies of air pollution: concepts and consequences. Environ Health Perspect (2000) 9.30
Molecular genetics of human color vision: the genes encoding blue, green, and red pigments. Science (1986) 8.23
Should paediatric intensive care be centralised? Trent versus Victoria. Lancet (1997) 8.08
Dissection of Mycobacterium tuberculosis antigens using recombinant DNA. Proc Natl Acad Sci U S A (1985) 7.46
Prevalence of patent foramen ovale in patients with stroke. N Engl J Med (1988) 5.94
A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol Cell (1998) 5.89
Large-scale discovery and genotyping of single-nucleotide polymorphisms in the mouse. Nat Genet (2000) 4.66
Cdc53 is a scaffold protein for multiple Cdc34/Skp1/F-box proteincomplexes that regulate cell division and methionine biosynthesis in yeast. Genes Dev (1998) 3.91
Mass and molecular composition of vesicular stomatitis virus: a scanning transmission electron microscopy analysis. J Virol (1985) 3.79
Isolation, characterization and structure of bacterial flagellar motors containing the switch complex. J Mol Biol (1994) 3.71
Sexual health of teenagers in England and Wales: analysis of national data. BMJ (1999) 3.54
Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol (2004) 3.52
CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci U S A (1997) 3.25
MGDS examination. Br Dent J (1989) 3.21
AREVA: multicenter randomized comparison of low-dose versus standard-dose anticoagulation in patients with mechanical prosthetic heart valves. Circulation (1996) 3.00
Acute lower respiratory tract infections in children: possible criteria for selection of patients for antibiotic therapy and hospital admission. Bull World Health Organ (1984) 2.97
Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res (1998) 2.93
Perivalvular abscesses associated with endocarditis; clinical features and prognostic factors of overall survival in a series of 233 cases. Perivalvular Abscesses French Multicentre Study. Eur Heart J (1999) 2.90
Distinct signals in human immunodeficiency virus type 1 Pr55 necessary for RNA binding and particle formation. J Gen Virol (1992) 2.89
An invasion-related complex of cortactin, paxillin and PKCmu associates with invadopodia at sites of extracellular matrix degradation. Oncogene (1999) 2.86
Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest. J Virol (1997) 2.82
Health and wages: evidence on men and women in urban Brazil. J Econom (1997) 2.75
Inducible nuclear expression of newly synthesized I kappa B alpha negatively regulates DNA-binding and transcriptional activities of NF-kappa B. Mol Cell Biol (1995) 2.69
Met31p and Met32p, two related zinc finger proteins, are involved in transcriptional regulation of yeast sulfur amino acid metabolism. Mol Cell Biol (1997) 2.68
Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions. Nat Med (2001) 2.66
Crystal structure of SIV matrix antigen and implications for virus assembly. Nature (1995) 2.59
Correlation of the highest-energy cosmic rays with nearby extragalactic objects. Science (2007) 2.57
Prognostic factors in bile duct carcinoma: analysis of 96 cases. Ann Surg (1981) 2.53
Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes. Blood (2000) 2.53
Characterization of recombinant gp120 and gp160 from HIV-1: binding to monoclonal antibodies and soluble CD4. AIDS (1990) 2.46
Requirement of human immunodeficiency virus type 1 nef for in vivo replication and pathogenicity. J Virol (1994) 2.45
Nuclear localization of I kappa B alpha promotes active transport of NF-kappa B from the nucleus to the cytoplasm. J Cell Sci (1997) 2.44
Bargaining power within couples and use of prenatal and delivery care in Indonesia. Stud Fam Plann (2001) 2.42
Secondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med (1989) 2.42
Cloning and expression in Escherichia coli of the OGG1 gene of Saccharomyces cerevisiae, which codes for a DNA glycosylase that excises 7,8-dihydro-8-oxoguanine and 2,6-diamino-4-hydroxy-5-N-methylformamidopyrimidine. Proc Natl Acad Sci U S A (1996) 2.36
Effects of immunity of Nippostrongylus brasiliensis adult worms: reversible and irreversible changes in infectivity, reproduction, and morphology. J Parasitol (1968) 2.35
Desflurane vaporiser contamination. Anaesthesia (2014) 2.35
Nucleation and growth phases in the polymerization of coat and scaffolding subunits into icosahedral procapsid shells. Biophys J (1993) 2.33
Vpr-induced cell cycle arrest is conserved among primate lentiviruses. J Virol (1996) 2.33
Randomized trial of a slow-release versus a standard formulation of cytarabine for the intrathecal treatment of lymphomatous meningitis. J Clin Oncol (1999) 2.29
Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease: beneficial effects of enoxaparin. French Investigators of the ESSENCE Trial. Circulation (1998) 2.28
Host antigens in schistosomiasis. Proc R Soc Lond B Biol Sci (1969) 2.24
Tissue specific regulation of VEGF expression during bone development requires Cbfa1/Runx2. Mech Dev (2001) 2.20
Characteristics of the tyrosine recognition signal for internalization of transmembrane surface glycoproteins. J Cell Biol (1990) 2.20
Three-dimensional transformation of capsids associated with genome packaging in a bacterial virus. J Mol Biol (1993) 2.16
Procedures used in withdrawal of mechanical ventilation. Am J Crit Care (1996) 2.15
The Panton-Valentine leukocidin vaccine protects mice against lung and skin infections caused by Staphylococcus aureus USA300. Clin Microbiol Infect (2008) 2.14
Measurement issues in environmental epidemiology. Environ Health Perspect (1993) 2.02
Feedback-regulated degradation of the transcriptional activator Met4 is triggered by the SCF(Met30 )complex. EMBO J (2000) 2.02
Scaffolding protein regulates the polymerization of P22 coat subunits into icosahedral shells in vitro. J Mol Biol (1988) 1.99
Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res (1993) 1.97
Acute release of plasminogen activator inhibitor-1 in ST-segment elevation myocardial infarction predicts mortality. Circulation (2003) 1.94
Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance. Diabetologia (2010) 1.89
Functional characterization of human gamma-aminobutyric acidA receptors containing the alpha 4 subunit. Mol Pharmacol (1996) 1.88
Normal prion protein has an activity like that of superoxide dismutase. Biochem J (1999) 1.87
Enhancement of clinician workflow with computer order entry. Proc Annu Symp Comput Appl Med Care (1995) 1.84
Multiple transcriptional activation complexes tether the yeast activator Met4 to DNA. EMBO J (1998) 1.84
Latency analysis in epidemiologic studies of occupational exposures: application to the Colorado Plateau uranium miners cohort. Am J Ind Med (1999) 1.80
Recent trends in HIV and other STIs in the United Kingdom: data to the end of 2002. Sex Transm Infect (2004) 1.79
A phase II study of 5-azacitidine for patients with primary and post-essential thrombocythemia/polycythemia vera myelofibrosis. Leukemia (2008) 1.79
Localization of RNA polymerases on influenza viral ribonucleoproteins by immunogold labeling. Virology (1988) 1.79
Design and analysis of multilevel analytic studies with applications to a study of air pollution. Environ Health Perspect (1994) 1.78
Prediction in family planning. Factors associated with involvement of low-income women in a public family planning program. Am J Public Health Nations Health (1970) 1.77
Blood transfusion and the anaesthetist: management of massive haemorrhage. Anaesthesia (2010) 1.77
Relaxation of recognition sequence of specific endonuclease HindIII. Nucleic Acids Res (1986) 1.74
Guidelines on the management of massive blood loss. Br J Haematol (2006) 1.72
Divergent evolution of pyrimidine biosynthesis between anaerobic and aerobic yeasts. Proc Natl Acad Sci U S A (1992) 1.72
Eukaryotic virus display: engineering the major surface glycoprotein of the Autographa californica nuclear polyhedrosis virus (AcNPV) for the presentation of foreign proteins on the virus surface. Biotechnology (N Y) (1995) 1.70
Stimulus Generalization as a Function of the Time between Training and Testing Procedures. J Exp Anal Behav (1960) 1.70
Use of gloves in veterinary practice. Vet Rec (1996) 1.70
Fate of the human immunodeficiency virus type 1 provirus in infected cells: a role for vpr. J Virol (1995) 1.69
Seroprevalence of human herpesvirus-8 (HHV-8) in countries of Southeast Asia compared to the USA, the Caribbean and Africa. Br J Cancer (1999) 1.68
Maintenance of some ColE1-type plasmids in chemostat culture. Mol Gen Genet (1980) 1.68
Schistosoma mansoni: changes in the outer membrane of the tegument during development from cercaria to adult worm. Int J Parasitol (1973) 1.67
Detection of a trimeric human immunodeficiency virus type 1 Gag intermediate is dependent on sequences in the matrix protein, p17. J Virol (1998) 1.66
Outcomes of macular hole surgery: implications for surgical management and clinical governance. Eye (Lond) (2005) 1.66
Risk factors for invasive cervical cancer among Latinas and non-Latinas in Los Angeles County. J Natl Cancer Inst (1986) 1.66
Comparative morphology of Gag protein structures produced by mutants of the gag gene of human immunodeficiency virus type 1. J Gen Virol (1994) 1.65
Nuclear calcium signalling by individual cytoplasmic calcium puffs. EMBO J (1997) 1.63
Assembly of a bZIP-bHLH transcription activation complex: formation of the yeast Cbf1-Met4-Met28 complex is regulated through Met28 stimulation of Cbf1 DNA binding. EMBO J (1997) 1.63
Missense mutations in disease genes: a Bayesian approach to evaluate causality. Am J Hum Genet (1998) 1.62
Relaxation of PvuII recognition sequence. FEBS Lett (1985) 1.62
V and C proteins of measles virus function as virulence factors in vivo. Virology (2000) 1.61
Association between air pollution and lung function growth in southern California children. Am J Respir Crit Care Med (2000) 1.60
Kikuchi's disease: an important cause of cervical lymphadenopathy. Clin Med (2007) 1.59
Effects of cisapride on QT interval in children. J Pediatr (1998) 1.59
Hepatitis C virus (HCV) infection in a community in the Nile Delta: population description and HCV prevalence. Hepatology (2000) 1.58
Visual hallucinations associated with fluoxetine and sertraline. J Clin Psychopharmacol (1998) 1.58
Measles virus infection in a transgenic model: virus-induced immunosuppression and central nervous system disease. Cell (1999) 1.56
Assembly of influenza ribonucleoprotein in vitro using recombinant nucleoprotein. Virology (1987) 1.56
Roles of matrix, p2, and N-terminal myristoylation in human immunodeficiency virus type 1 Gag assembly. J Virol (2000) 1.55
Acid phosphatases. Mol Pathol (2002) 1.55
SCF(Met30)-mediated control of the transcriptional activator Met4 is required for the G(1)-S transition. EMBO J (2000) 1.55